Financials
- Market Capitalization 3.13 B
- Employee 601
- Founded 2015
- CEO -
- Website www.arcusbio.com
- Headquarter Delaware, United States
- FIGI BBG00DQD26W3
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-7.24
Rapporto prezzo/fatturato
10.36
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1595 | CELC Celcuity Inc. - Common Stock | 66.75 USD | -1.75% | -5.87% | -19.92% | +42.48% | 3.27 B USD | ||
| 1622 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 27.80 USD | -1.21% | +0.65% | -12.69% | +95.22% | 3.10 B USD | ||
| 1639 | DYN Dyne Therapeutics, Inc. - Common Stock | 16.21 USD | -2.58% | +5.12% | -11.90% | -30.76% | 3.03 B USD | ||
| 1644 | DNLI Denali Therapeutics Inc. - Common Stock | 19.07 USD | -1.95% | -3.83% | -9.58% | +17.93% | 3.05 B USD |